Jesús Pérez-Pazos

Jesús Pérez-Pazos

Auto-generated profile, based on publicly available information

Jesús Pérez-Pazos

Department of Psychiatry, University Hospital Vall d'Hebron, CIBERSAM, Barcelona, Spain

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 April 2014 in Journal of Attention Disorders
Verified
Journal Article
Closed access
CDConstanza Daigre
Constanza Daigre
CRCarlos Roncero
Carlos Roncero
LRLaia Rodríguez-Cintas
Laia Rodríguez-Cintas
LOLluisa Ortega
Lluisa Ortega
ALAnna Lligoña
Anna Lligoña
MCMiquel Casas
Miquel Casas
Objective: The aim was to analyze the psychometric properties of two screening instruments, Wender-Utah Rating Scale (WURS) that evaluates childhood ADHD and Adult ADHD Self-Report Scales (ASRS) that assesses symptoms in adulthood, in alcohol-dependent patients. Method: A total of 355 outpatients were included. Conners’ adult ADHD diagnostic interview results were used as a gold standard in childhood and adulthood ADHD. Results: The WURS with a 41 cutoff had a sensitivity of 79.6% and a specificity of 60.3%. The ASRS with a 14 cutoff had a sensitivity of 86.7% and specificity of 66.1%. Analyzing both rating scales in combination, it was observed that patients with positive ASRS and WURS presented a sensitivity of 92.3%. Patients with positive ASRS, but negative WURS, presented a specificity of 73.6%. Conclusion: WURS and ASRS are useful tools in the diagnosis of adult ADHD in alcohol-dependent patients; with the use of both instruments, the psychometric properties are substantially improved.

13 June 2014 in Substance Abuse
Verified
Journal Article
Closed access
CRCarlos Roncero
Carlos Roncero
CDCostanza Daigre
Costanza Daigre
LGLara Grau-López
Lara Grau-López
CBCarmen Barral
Carmen Barral
JPJesus Pérez-Pazos
Jesus Pérez-Pazos
MCMiquel Casas
Miquel Casas
Cocaine use can induce transient psychotic symptoms that include suspiciousness, paranoia, hallucinations, and other cocaine-related behaviors. In this commentary, the authors provide an international perspective while reviewing the recent advances in epidemiology, clinical features, and risk factors related to cocaine-induced psychosis exhibited by patients with cocaine use disorders. In some settings, the occurrence of cocaine-induced psychosis has been shown to be as high as 86.5%. Many risk factors have been linked with cocaine-induced psychosis, including the quantity of cocaine consumed, lifetime amount of cocaine use, onset of cocaine dependence, years of use, routes of administration, other substance use disorder comorbidity, weight, gender, comorbidity with other medical and mental health disorders, genetics, and pharmacological interactions. Research has shown that the evaluation of cocaine-induced psychosis in patients with cocaine use is clinically relevant, especially in those patients who consume high amounts of cocaine, have a cannabis dependence history, have antisocial personality disorder, use administration routes other than intranasal, or exhibit attention-deficit/hyperactivity disorder (ADHD) comorbidity. Currently, the literature lacks information regarding the evolution of cocaine dependence or cocaine-dependent patients’ risk for developing schizophrenia or other psychotic disorders. Furthermore, clinicians still do not have an evidence-based pharmacological approach to management of cocaine dependence available to them. Additional research is also needed regarding risk factors such as neurobiological markers and personality traits. Finally, we recommend the development of an integrative model including all of the risk factors and protective factors for cocaine-induced psychosis.

1 July 2013 in Journal of Addictive Diseases
Verified
Journal Article
Closed access
CRCarlos Roncero
Carlos Roncero
CDConstanza Daigre
Constanza Daigre
LGLara Grau-López
Lara Grau-López
LMLaia Rodríguez-Cintas Ma
Laia Rodríguez-Cintas Ma
CBCarmen Barral
Carmen Barral
MCMiquel Casas
Miquel Casas
Cocaine-dependent patients have high impulsiveness. Cocaine-induced psychosis is common among cocaine-dependent patients. Different risk factors associated with cocaine-induced psychosis have been reported. The aim of this study is to analyze the relationship between psychotic symptoms in cocaine-dependent patients and impulsivity and mental disorders characterized by impulsivity. This descriptive study included 287 outpatients with cocaine dependence according to the DSM-IV-TR criteria. The Structured Clinical Interview for DSM-IV Axis I and II, the Barratt Impulsiveness Scale, and a specific questionnaire on the presence of cocaine-induced psychosis were used to assess patients. Symptoms were observed in 59.9% of the study population. Total and cognitive impulsiveness scores obtained from the Barratt Impulsiveness Scale were significantly higher in patients with cocaine-induced psychosis. Individuals from this group reported more overdose incidents, initiated more treatments during their lifetime, and had a significantly greater prevalence of attention deficit hyperactivity disorder. Patients with cocaine-induced psychosis have a greater degree of impulsivity and a higher prevalence of attention deficit hyperactivity disorder. Thus, if these disorders are observed in cocaine-dependent participants, the presence of psychotic symptoms should be evaluated to prevent further occurrence and their consequences.

1 May 2015
Verified
Journal Article
Closed access
CRCarlos Roncero
Carlos Roncero
AEAngel Egido
Angel Egido
LRLaia Rodríguez-Cintas
Laia Rodríguez-Cintas
JPJesús Pérez-Pazos
Jesús Pérez-Pazos
FCFrancisco Collazos
Francisco Collazos
MCMiquel Casas
Miquel Casas

1 April 2013 in Substance Abuse
Verified
Journal Article
Closed access
CRCarlos Roncero
Carlos Roncero
NMNieves Martínez-Luna
Nieves Martínez-Luna
CDConstanza Daigre
Constanza Daigre
LGLara Grau-López
Lara Grau-López
BGBegoña Gonzalvo
Begoña Gonzalvo
MCMiquel Casas
Miquel Casas
Background: Psychotic symptoms are common among cocaine users. Methods: An observational naturalistic study on the effects and events of intravenous cocaine use in a drug consumption room was carried out; the patients were diagnosed of cocaine dependence (according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision). Results: Twenty-one patients, 81% men self-injected cocaine 375 times. Psychotic symptoms were observed in 62% of the patients and 21% of the self-injections; delusions were observed in 9.3%, psychotic self-reference with insight in 9.1%, illusions in 6.4%, and hallucinations in 5.3%. A higher presence of psychotic symptoms was noted with cannabis used in the previous month (76.9% versus 44.4%; P = .001) (no psychotic symptoms group); also, a greater use of benzodiazepines was observed: 75.6% versus 63.6% (P = .046). Lower use of methadone in the group with psychosis was observed: 75.6% versus 97.3% (P = .001). Motor alterations were tremor 58%, stereotyped movements 24%, and behaviour alteration 6%, significantly more frequent in the psychotic group. Conclusions: Thus, there was a high frequency of psychotic symptoms after intravenous cocaine use; patients with psychotic symptoms reported higher use of cannabis and benzodiazepines in the previous month and lower use of methadone. More tremors and stereotyped movements were observed in the group with psychotic symptoms. It is necessary to give a special approach to cocaine intravenous users.